OMIC实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Jun 2024 @ 04:00):
Our systems believe the stock currently is undervalued by 0.55% compare to its pairs and should correct upwards.

Stats
今日成交量	18 861
平均成交量	5 536
市值	20.87M
EPS	$-0.340 ( Q1 \| 2024-05-14 )
下一个收益日期	( $-8.88 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.220 (Sector) 42.63 (Industry) 78.56
ATR14	$0.222 (2.61%)

GCTK 0.50%

GMVDW -1.13%

LUCY 50.00%

LUCYW 2.97%

NXGLW 0.00%

NYXH -0.57%

OMIC -9.33%

POCI 0.51%

Insider Trading

Date	Person	Action	Amount	type
2024-06-15	Meeter Dalen	Buy	6 250	Common Stock
2024-06-15	Meeter Dalen	Sell	6 250	Restricted Stock Units
2024-06-15	Glezer Eli N.	Buy	7 500	Common Stock
2024-06-15	Glezer Eli N.	Sell	7 500	Restricted Stock Units
2024-06-15	Spaventa Andrew	Buy	14 584	Common Stock

INSIDER POWER
44.10
Last 98 transactions
Buy: 5 152 178 \| Sell: 2 090 858

相关性 (AI algo v.1.1b): Undervalued: 0.55% $8.55 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: -0.04 (neutral)

短: -0.54 (weak negative)

Signal:(36.887) Neutral

Singular Genomics 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Singular Genomics 相关性 - 货币/商品

-0.16
( neutral )

-0.39
( neutral )

0.04
( neutral )

-0.11
( neutral )

-0.39
( neutral )

0.53
( weak )

Singular Genomics 财务报表

Annual	2023
营收:	$2.91M
毛利润:	$-558 000 (-19.17 %)
EPS:	$-1.300

FY	2023
营收:	$2.91M
毛利润:	$-558 000 (-19.17 %)
EPS:	$-1.300

FY	2022
营收:	$765 000
毛利润:	$-24 000.00 (-3.14 %)
EPS:	$-1.240

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.377

Financial Reports:

No articles found.

Singular Genomics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Singular Genomics

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.